Published On: Mon, May 9th, 2016
Uncategorized | By Sylvia Delisle

Latest Analyst Reports On Baxalta


Recently stock market analysts have updated their consensus ratings on shares of Baxalta (NYSE:BXLT).

Most recent broker ratings

02/17/2016 – Baxalta had its “buy” rating reiterated by analysts at UBS. They now have a USD 46 price target on the stock.

12/09/2015 – Baxalta had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 40 price target on the stock.

10/27/2015 – Baxalta had its “buy” rating reiterated by analysts at William Blair.

10/09/2015 – Baxalta had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 42 price target on the stock.

08/11/2015 – Baxalta had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 42 price target on the stock.

07/21/2015 – Baxalta had its “hold” rating reiterated by analysts at JP Morgan.

07/16/2015 – Citigroup began new coverage on Baxalta giving the company a “buy” rating. They now have a USD 40 price target on the stock.

07/13/2015 – Deutsche Bank began new coverage on Baxalta giving the company a “hold” rating. They now have a USD 32 price target on the stock.

07/02/2015 – Goldman Sachs began new coverage on Baxalta giving the company a “neutral” rating. They now have a USD 36 price target on the stock.

07/01/2015 – Baxalta was upgraded to “equal-weight” by analysts at Morgan Stanley.

Baxalta has a 50 day moving average of 40.72 and a 200 day moving average of 38.38. The stock’s market capitalization is 27.93B, it has a 52-week low of 29.83 and a 52-week high of 42.85.

The share price of the company (NYSE:BXLT) was down -0.41%, with a high of 41.44 during the day and the volume of Baxalta shares traded was 9814731.

View other investors thoughts on Baxalta with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.

Receive News & Ratings Via Email


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Navigation